Search

Your search keyword '"Hite, R. Duncan"' showing total 221 results

Search Constraints

Start Over You searched for: Author "Hite, R. Duncan" Remove constraint Author: "Hite, R. Duncan"
221 results on '"Hite, R. Duncan"'

Search Results

1. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

2. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

3. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

4. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

5. Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

6. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

7. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome

8. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness

9. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

10. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome.

11. Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

13. Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome*.

14. Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome

15. Rosuvastatin for sepsis-associated acute respiratory distress syndrome.

16. Vascular pedicle width in acute lung injury: correlation with intravascular pressures and ability to discriminate fluid status

18. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

21. Tixagevimab/Cilgavimab for Treatment of Hospitalised COVID-19 Patients: A Randomised, Double-Blind, Phase 3 Trial

24. mTORC1 is a mechanosensor that regulates surfactant function and lung compliance during ventilator-induced lung injury

27. Implementation of Protocolized Care in ARDS Improves Outcomes

28. Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction

29. Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase [A.sub.2]-mediated surfactant dysfunction

33. List of Contributors

35. Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure

39. Response

40. Three Alveolar Phenotypes Govern Lung Function in Murine Ventilator-Induced Lung Injury

43. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure

44. Efficacy of extracorporeal membrane oxygenation in 2009 influenza A (H1N1)

45. Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2

46. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome

49. Implementation of Protocolized Care in ARDS Improves Outcomes.

Catalog

Books, media, physical & digital resources